Responders to ChEI treatment of Alzheimer's disease show restitution of normal regional cortical activation

Annalena Venneri, William J. McGeown, Michael F. Shanks

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Clinical trials of cholinesterase inhibitor (ChEI) drugs, although generally reporting only minimal improvements in patients with Alzheimer's disease ( AD), indicate that a subgroup of patients may respond substantially to treatment. This study aimed to assess the clinically variable ChEI treatment effects in a group of patients with mild AD using a semantic association and an N-back light working memory activation paradigm. Twenty-six patients with probable mild AD treated with a ChEI for 20 weeks were retrospectively divided into responders and non-responders. Patients were classified as responders if their Clinician's Interview Based Impression of Change (CIBIC - Plus) score was four or less and if they had an increase of at least two points on the MMSE. These criteria resulted in two subgroups comprising nine responders and seventeen non responders. Nine healthy elderly age-matched controls were also recruited as a comparison group. ChEI treatment was accompanied by significant modulation of task induced activation increases in both fMRI tasks in AD responders. The effect of ChEI response was in effect a restoration of regional brain function in the same areas used by elderly controls when performing these tasks. In non-responders decrements in task related activation were observed and over time activation patterns appeared less like the elderly controls. Screening semantic fluency scores correlated negatively with activation increases at retest. In the paper, a tentative explanation is offered of why subgroups of patients with a similar clinical diagnosis and level of clinical severity show a different physiological response to ChE inhibition.

Fingerprint

Cholinesterase Inhibitors
Alzheimer Disease
Semantics
Therapeutics
Short-Term Memory
Magnetic Resonance Imaging
Clinical Trials
Interviews
Light
Brain
Pharmaceutical Preparations

Keywords

  • mild cognitive impairment
  • Donepezil treatment
  • cerebral-blood-flow
  • treatment
  • Alzheimer's disease
  • dementia
  • vascular dementia
  • rivastigmine treatment
  • fMRI
  • cholinergic enhancement
  • substantia innominata
  • ChEI
  • mental-state-examination

Cite this

@article{765068b1ee9646faa9c42d8ad9310064,
title = "Responders to ChEI treatment of Alzheimer's disease show restitution of normal regional cortical activation",
abstract = "Clinical trials of cholinesterase inhibitor (ChEI) drugs, although generally reporting only minimal improvements in patients with Alzheimer's disease ( AD), indicate that a subgroup of patients may respond substantially to treatment. This study aimed to assess the clinically variable ChEI treatment effects in a group of patients with mild AD using a semantic association and an N-back light working memory activation paradigm. Twenty-six patients with probable mild AD treated with a ChEI for 20 weeks were retrospectively divided into responders and non-responders. Patients were classified as responders if their Clinician's Interview Based Impression of Change (CIBIC - Plus) score was four or less and if they had an increase of at least two points on the MMSE. These criteria resulted in two subgroups comprising nine responders and seventeen non responders. Nine healthy elderly age-matched controls were also recruited as a comparison group. ChEI treatment was accompanied by significant modulation of task induced activation increases in both fMRI tasks in AD responders. The effect of ChEI response was in effect a restoration of regional brain function in the same areas used by elderly controls when performing these tasks. In non-responders decrements in task related activation were observed and over time activation patterns appeared less like the elderly controls. Screening semantic fluency scores correlated negatively with activation increases at retest. In the paper, a tentative explanation is offered of why subgroups of patients with a similar clinical diagnosis and level of clinical severity show a different physiological response to ChE inhibition.",
keywords = "mild cognitive impairment, Donepezil treatment, cerebral-blood-flow, treatment, Alzheimer's disease, dementia, vascular dementia, rivastigmine treatment, fMRI, cholinergic enhancement, substantia innominata, ChEI, mental-state-examination",
author = "Annalena Venneri and McGeown, {William J.} and Shanks, {Michael F.}",
year = "2009",
month = "4",
doi = "10.2174/156720509787602933",
language = "English",
volume = "6",
pages = "97--111",
journal = "Current Alzheimer Research",
issn = "1567-2050",
number = "2",

}

Responders to ChEI treatment of Alzheimer's disease show restitution of normal regional cortical activation. / Venneri, Annalena; McGeown, William J.; Shanks, Michael F.

In: Current Alzheimer Research, Vol. 6, No. 2, 04.2009, p. 97-111.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Responders to ChEI treatment of Alzheimer's disease show restitution of normal regional cortical activation

AU - Venneri, Annalena

AU - McGeown, William J.

AU - Shanks, Michael F.

PY - 2009/4

Y1 - 2009/4

N2 - Clinical trials of cholinesterase inhibitor (ChEI) drugs, although generally reporting only minimal improvements in patients with Alzheimer's disease ( AD), indicate that a subgroup of patients may respond substantially to treatment. This study aimed to assess the clinically variable ChEI treatment effects in a group of patients with mild AD using a semantic association and an N-back light working memory activation paradigm. Twenty-six patients with probable mild AD treated with a ChEI for 20 weeks were retrospectively divided into responders and non-responders. Patients were classified as responders if their Clinician's Interview Based Impression of Change (CIBIC - Plus) score was four or less and if they had an increase of at least two points on the MMSE. These criteria resulted in two subgroups comprising nine responders and seventeen non responders. Nine healthy elderly age-matched controls were also recruited as a comparison group. ChEI treatment was accompanied by significant modulation of task induced activation increases in both fMRI tasks in AD responders. The effect of ChEI response was in effect a restoration of regional brain function in the same areas used by elderly controls when performing these tasks. In non-responders decrements in task related activation were observed and over time activation patterns appeared less like the elderly controls. Screening semantic fluency scores correlated negatively with activation increases at retest. In the paper, a tentative explanation is offered of why subgroups of patients with a similar clinical diagnosis and level of clinical severity show a different physiological response to ChE inhibition.

AB - Clinical trials of cholinesterase inhibitor (ChEI) drugs, although generally reporting only minimal improvements in patients with Alzheimer's disease ( AD), indicate that a subgroup of patients may respond substantially to treatment. This study aimed to assess the clinically variable ChEI treatment effects in a group of patients with mild AD using a semantic association and an N-back light working memory activation paradigm. Twenty-six patients with probable mild AD treated with a ChEI for 20 weeks were retrospectively divided into responders and non-responders. Patients were classified as responders if their Clinician's Interview Based Impression of Change (CIBIC - Plus) score was four or less and if they had an increase of at least two points on the MMSE. These criteria resulted in two subgroups comprising nine responders and seventeen non responders. Nine healthy elderly age-matched controls were also recruited as a comparison group. ChEI treatment was accompanied by significant modulation of task induced activation increases in both fMRI tasks in AD responders. The effect of ChEI response was in effect a restoration of regional brain function in the same areas used by elderly controls when performing these tasks. In non-responders decrements in task related activation were observed and over time activation patterns appeared less like the elderly controls. Screening semantic fluency scores correlated negatively with activation increases at retest. In the paper, a tentative explanation is offered of why subgroups of patients with a similar clinical diagnosis and level of clinical severity show a different physiological response to ChE inhibition.

KW - mild cognitive impairment

KW - Donepezil treatment

KW - cerebral-blood-flow

KW - treatment

KW - Alzheimer's disease

KW - dementia

KW - vascular dementia

KW - rivastigmine treatment

KW - fMRI

KW - cholinergic enhancement

KW - substantia innominata

KW - ChEI

KW - mental-state-examination

U2 - 10.2174/156720509787602933

DO - 10.2174/156720509787602933

M3 - Article

VL - 6

SP - 97

EP - 111

JO - Current Alzheimer Research

T2 - Current Alzheimer Research

JF - Current Alzheimer Research

SN - 1567-2050

IS - 2

ER -